Have a feature idea you'd love to see implemented?
Let us know!
NURO NeuroMetrix Inc
Price (delayed)
$4.15
Market cap
$8.41M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.48
Enterprise value
$6.98M
NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of disorders involving the nervous system. The Company has
Highlights
NeuroMetrix's debt has decreased by 41% YoY and by 16% QoQ
NURO's EPS is up by 13% QoQ and by 5% YoY
NURO's quick ratio is down by 38% year-on-year but it is up by 7% since the previous quarter
NURO's net income is down by 47% YoY
NeuroMetrix's gross profit has decreased by 45% YoY and by 19% from the previous quarter
Key stats
What are the main financial stats of NURO
Market
Valuations
Earnings
Shares outstanding
2.03M
Market cap
$8.41M
Enterprise value
$6.98M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.48
Price to sales (P/S)
1.89
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.59
Revenue
$4.38M
EBIT
-$7.94M
EBITDA
-$7.78M
Free cash flow
-$7.14M
Per share
Balance sheet
Liquidity
EPS
-$5.48
Free cash flow per share
-$3.57
Book value per share
$8.61
Revenue per share
$2.19
TBVPS
$9.46
Total assets
$18.93M
Total liabilities
$1.62M
Debt
$176,601
Equity
$17.31M
Working capital
$16.89M
Debt to equity
0.01
Current ratio
11.62
Quick ratio
10.51
Net debt/EBITDA
0.18
Margins
Efficiency
Dividend
EBITDA margin
-177.6%
Gross margin
60.2%
Net margin
-181%
Operating margin
-203%
Return on assets
-38.6%
Return on equity
-41.7%
Return on invested capital
-44.6%
Return on capital employed
-45.8%
Return on sales
-181%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NURO stock price
How has the NeuroMetrix stock price performed over time
Intraday
3.49%
1 week
1.9%
1 month
5.6%
1 year
-22.72%
YTD
15.28%
QTD
4.53%
Financial performance
How have NeuroMetrix's revenue and profit performed over time
Revenue
$4.38M
Gross profit
$2.64M
Operating income
-$8.9M
Net income
-$7.94M
Gross margin
60.2%
Net margin
-181%
NURO's operating margin has shrunk by 148% YoY and by 23% QoQ
NeuroMetrix's net margin has shrunk by 141% YoY and by 19% QoQ
NURO's operating income has dropped by 51% year-on-year and by 2.4% since the previous quarter
NURO's net income is down by 47% YoY
Growth
What is NeuroMetrix's growth rate over time
Valuation
What is NeuroMetrix stock price valuation
P/E
N/A
P/B
0.48
P/S
1.89
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.59
NURO's EPS is up by 13% QoQ and by 5% YoY
The P/B is 60% above the last 4 quarters average of 0.3 but 56% below the 5-year quarterly average of 1.1
The equity has declined by 19% year-on-year and by 8% since the previous quarter
The stock's price to sales (P/S) is 58% more than its last 4 quarters average of 1.2
NURO's revenue is down by 39% year-on-year and by 17% since the previous quarter
Efficiency
How efficient is NeuroMetrix business performance
NURO's ROS has shrunk by 141% YoY and by 19% QoQ
NeuroMetrix's ROE has plunged by 71% YoY and by 4.8% from the previous quarter
NURO's ROA has plunged by 69% YoY and by 4% from the previous quarter
The ROIC has plunged by 66% YoY and by 5% from the previous quarter
Dividends
What is NURO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NURO.
Financial health
How did NeuroMetrix financials performed over time
NURO's quick ratio is down by 38% year-on-year but it is up by 7% since the previous quarter
The current ratio has contracted by 37% YoY but it has grown by 7% from the previous quarter
NeuroMetrix's debt is 99% lower than its equity
NeuroMetrix's debt has decreased by 41% YoY and by 16% QoQ
The equity has declined by 19% year-on-year and by 8% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.